Climacteric syndrome. A nutritional approach to treatment
DOI: 10.32364/2618-8430-2020-3-3-189-193
L.V. Saprykina, M.R. Narimanova, D.M. Ibragimova
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Female sex hormones are of crucial importance for a woman’s life. Almost all women over 40 irrespective of their origin or social status begin to experience physical, psychologic, and emotional problems. Menopause hormone therapy (MHT) is considered the most effective option to improve various symptoms of climacteric syndrome. Non-hormonal treatment can be an alternative to MHT to relieve the symptoms of climacteric symptoms in pre- and postmenopausal women, in particular, in contraindications or reluctance to take MHT. The paper addresses recent findings on the effects of soy isoflavones, β-alanine, tryptophan, and vitamins on tissues and the quality of life of pre- and postmenopausal women. Mense® (JC «Akvion»), a biologically active supplement that contains phytoestrogens, vitamins, and amino acids, is characterized by a variety of protective effects in pre- and postmenopausal periods. This biologically active supplement can be recommended for women with the symptoms of climacteric syndrome as a pretreatment during the screening before prescribing MHT, a dietary modification in contraindications or refusal of MHT, and/or an effective component of the complex treatment for climacteric syndrome.
Keywords: perimenopause, postmenopause, non-hormonal treatment, menopause hormone therapy, vasomotor symptoms, phytoestrogens, vitamins.
For citation: Saprykina L.V., Narimanova M.R., Ibragimova D.M. Climacteric syndrome. A nutritional approach to treatment. Russian Journal of Woman and Child Health. 2020;3(3):189–193. DOI: 10.32364/2618-8430-2020-3-3-189-193.
Acknowledgment
Editorial Board is grateful to JC "Akvion" for the assistance in technical edition of this publication.
Сведения об авторах:
Сапрыкина Людмила Витальевна — к.м.н., ассистент кафедры акушерства и гинекологии лечебного факультета, ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, Россия, г. Москва, ул. Островитянова, д. 1, ORCID iD 0000-0002-2931-0956.
Нариманова Метанат Рафиговна — к.м.н., ассистент кафедры акушерства и гинекологии, ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, Россия, г. Москва, ул. Островитянова, д. 1, ORCID iD 0000-0003-0677-2952.
Ибрагимова Джамиля Магомедовна — к.м.н., доцент кафедры акушерства и гинекологии, ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, Россия, г. Москва, ул. Островитянова, д. 1, ORCID iD 0000-0002-8738-868X.
Контактная информация: Сапрыкина Людмила Витальевна, e-mail: lioudsap@yandex.ru. Прозрачность финансовой деятельности: никто из авторов не имеет финансовой заинтересованности в представленных материалах или методах. Конфликт интересов отсутствует. Статья поступила 27.07.2020, поступила после рецензирования 10.08.2020, принята в печать 24.08.2020.
About the authors:
Lyudmila V. Saprykina — Cand. of Sci. (Med.), assistant of the Department of Obstetrics & Gynecology, Pirogov Russian National Research Medical University, 1, Ostrovityanov str., Moscow, 117437, Russian Federation; ORCID iD 0000-0002-2931-0956.
Metanat R. Narimanova — Cand. of Sci. (Med.), assistant of the Department of Obstetrics & Gynecology, Pirogov Russian National Research Medical University, 1, Ostrovityanov str., Moscow, 117437, Russian Federation; ORCID iD 0000-0003-0677-2952.
Dzhamilya M. Ibragimova — Cand. of Sci. (Med.), associate professor of the Department of Obstetrics & Gynecology, Pirogov Russian National Research Medical University, 1, Ostrovityanov str., Moscow, 117437, Russian Federation; ORCID iD 0000-0002-8738-868X.
Contact information: Lyudmila V. Saprykina, e-mail: lioudsap@yandex.ru. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 27.07.2020, revised 10.08.2020, accepted 24.08.2020.
2. El Hajj A., Wardy N., Haidar S. et al. Menopausal symptoms, physical activity level and quality of life of women living in the Mediterranean region. PLoS One. 2020;15(3): e0230515. DOI: 10.1371/journal.pone.0230515.
3. Балан В.Е., Рафаэлян И.В., Левкович Е.А. и др. Особенности длительного применения фитоэстрогенов для лечения пациенток с климактерическим синдромом. Российский вестник акушера-гинеколога. 2013;5:58–62. [Balan V.E., Rafalian I.V., Levkovich E.A. et al. Specific features of long-term use of phytoestrogens to treat patients with climacteric syndrome. Russian Bulletin of Obstetrician and Gynecologist. 2013;5:58–62 (in Russ.)].
4. Gracia C.R., Freeman E.W. Onset of the menopause transition: the earliest signs and symptoms. Obstet Gynecol Clin North Am. 2018;45:585–597. DOI: 10.1016/j.ogc.2018.07.002.
5. Ward K., Deneris A. An update on menopause management. J Midwifery Womens Health. 2018;63:168–177. DOI: 10.1111/jmwh.12737.
6. Takahashi T.A., Johnson K.M. Menopause. Med Clin North Am. 2015;99:521–534. DOI: 10.1016/j.mcna.2015.01.006.
7. Avis N.E., Crawford S.L., Greendale G. et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–539. DOI: 10.1001/jamainternmed.2014.8063.
8. Andenæs R., Småstuen M.C., Misvær N. et al. Associations between menopausal hormone therapy and sleep disturbance in women during the menopausal transition and post-menopause: data from the Norwegian prescription database and the HUNT study. BMC Womens Health. 2020;20(1):64. DOI: 10.1186/s12905-020-00916-8.
9. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728–753. DOI: 10.1097/GME.0000000000000921.
10. Сухих Г.Т., Сметник В.П., Андреева Е.Н. и др. Менопаузальная гормонотерапия и сохранение здоровья женщин в зрелом возраста: клинические рекомендации (протокол лечения). М.; 2014. [Sukhih G.T., Smetnik V.P. Andreeva E.N. et al. Menopausal hormonal therapy and saving of women’s midlife health. Clinical recommendations (treatment protocol). M.; 2014 (in Russ.)].
11. Milart P., Woźniakowska E., Wojciech Wrona W. Selected vitamins and quality of life in menopausal women. Prz Menopauzalny. 2018;17(4):175–179. DOI: 10.5114/pm.2018.81742.
12. Daley A., Stokes-Lampard H., Thomas A., MacArthur C. Exercise for vasomotor menopausal symptoms. Cochrane Systematic Review. 2014;(11): CD006108. DOI: 10.1002/14651858.CD006108.pub4.
13. Доброхотова Ю.Э., Сапрыкина Л.В. Тофизопам: возможности негормональной терапии нейровегетативных и психоэмоциональных нарушений при климактерическом синдроме. Медицинский совет. 2017;2:88–91. [Dobrokhotova Yu.E., Saprykina L.V. Tofisopam: prospects for non-hormonal therapy of neuro-vegetative and psycho-emotional disorders associated with menopausal syndrome. Medical Council. 2017;2:88–91 (in Russ.)]. DOI: 10.21518/2079-701X-2017-2-88-91.
14. Fait T. Menopause hormone therapy: Latest developments and clinical practice. Drugs Context. 2019;8:1–9. DOI: 10.7573/dic.212551.
15. Thomas A.J., Ismail R., Taylor-Swanson L. et al. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: A systematic review. Maturitas. 2014;78:263–276. DOI: 10.1016/j.maturitas.2014.05.007.
16. Roberts H., Lethaby A. Phytoestrogens for menopausal vasomotor symptoms: A Cochrane review summary. Maturitas. 2014;78:79–81. DOI: 10.1016/j.maturitas.2014.04.004.
17. Okekunle A.P., Gao J., Wu X. et al. Higher dietary soy intake appears inversely related to breast cancer risk independent of estrogen receptor breast cancer phenotypes. Heliyon. 2020;6(7): e04228. DOI: 10.1016/j.heliyon.2020.e04228.
18. Roozbeh N., Kashef R., Ghazanfarpour M. et al. Overview of the effect of herbal medicines and isoflavones on the treatment of cognitive function. J Menopausal Med. 2018;24:113–118. DOI: 10.6118/jmm.2018.24.2.113.
19. Gryszczynska A., Gryszczynska B., Opala B., Lowicki Z. Plants supporting the fight against the symptoms of menopause. Wiad Lek. 2013;66(1):58–61.
20. Andreeva E., Tkeshelashvili B. Women dealing with hot flushes: the role of β-alanine. Eur Rev Med Pharmacol Sci. 2020;24:5148–5154. DOI: 10.26355/eurrev_202005_21209.
21. O’Connor D.L., Blake J., Bell R. et al; Nutrition Working Group. Canadian consensus on female nutrition: adolescence, reproduction, menopause and beyond. J Obstet Gynaecol Can. 2016;38:508–554. DOI: 10.1016/j.jogc.2016.01.001.
22. Porter K., Hoey L., Hughes C.F. et al. Causes, consequences and public health implications of low B-vitamin status in ageing. Nutrients. 2016;8:1–29. DOI: 10.3390/nu8110725.
23. Araujo J.R., Martel F., Borges N. et al. Folates and aging: Role in mild cognitive impairment, dementia and depression. Ageing Res Rev. 2015;22:9–19. DOI: 10.1016/j.arr.2015.04.005.
24. Smith D.A., Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211–239. DOI: 10.1146/annurev-nutr-071715-050947.
25. Enneman A.W., Swart K.M., VanWijngaarden J.P. et al. Association between plasma homocysteine and bone density and quality parameters in the elderly. Bone. 2012;50: S134. DOI: 10.1016/j.bone.2014.03.002.
26. Yang J., Hu X., Zhang Q. et al. Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone. 2012;51:376–382. DOI: 10.1016/j.bone.2012.05.024.
27. Vijayakumar T.M., Pavitra K., Muthunarayanan L. Comparative assessment of methylcobalamin and ascorbic acid on cognitive function in post-menopausal women — A randomized, double-blind trial. Contemp Clin Trials Comm. 2017;8:175–180. DOI: 10.1016/j.conctc.2017.10.006.
28. Ataei-Almanghadim K., Farshbaf-Khalili A., Ostadrahimi A.R. et al. The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial. Complement Ther Med. 2020;48:102267. DOI: 10.1016/j.ctim.2019.102267.
29. Ших Е.В., Гребенщикова Л.Ю. Рациональная дотация микронутриентов как способ повышения качества жизни у пациенток с климактерическим синдромом. Медицинский совет. 2017;13:104–109. [Shikh E.V., L.Y. Grebenshhikova L.Y. A rational grant of micronutrients as a way to improve quality of life of climacteric syndrome patients. Medical Council. 2017;13:104–109 (in Russ.)]. DOI: 10.21518/2079-701X-2017-13-166-171.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
